KEY BENEFITS Increases fat metabolism and lean muscle development
FDA registration of the facility does not constitute FDA approval or endorsement of any compounded medication.
Who Qualifies for GLP-1 Therapy
The events manifested soon after the initiation of GLP-1 RA treatment, with a median onset time of 92 days (range: 03,312, n = 1,591) across all ICSRs that provided both drug initiation and AP onset times
For long-term storage (months to years), it should be kept in a freezer, ideally below -20C (-4F)
T1D Fund portfolio company i2O Therapeutics is developing several products leveraging GLP-1s, initially for T2D, including a refillable, implantable GLP-1 device that delivers 6 months worth of the hormone, an oral form of long acting GLP-1, as well as a combined oral GLP-1 with Amylin (another important gut hormone)